Changes in use of multiplex respiratory panel testing during the COVID-19 pandemic
Infection Control & Hospital Epidemiology · 2024
DOI: 10.1017/ice.2024.163 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Infection Control & Hospital Epidemiology, 2024. Verfasst von Jonathan D Baghdadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Testing, Respiratory Tract Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS.
Abstract (Originalsprache)
Background
COVID-19 changed the epidemiology of community-acquired respiratory viruses. We explored patterns of respiratory viral testing to understand which tests are most clinically useful in the postpandemic era.
Methods
We conducted a retrospective observational study of discharge data from PINC-AI (formerly Premier), a large administrative database. Use of multiplex nucleic acid amplification respiratory panels in acute care, including small (2–5 targets), medium (6–11), and large panels (>11), were compared between the early pandemic (03/2020–10/2020), late pandemic (11/2020–4/2021), and prepandemic respiratory season (11/2019 - 02/2020) using ANOVA.
Results
A median of 160.5 facilities contributed testing data per quarter (IQR 155.5–169.5). Prepandemic, facilities averaged 103 respiratory panels monthly (sd 138), including 79 large (sd 126), 7 medium (sd 31), and 16 small panels (sd 73). Relative to prepandemic, utilization decreased during the early pandemic (62 panels monthly/facility; sd 112) but returned to the prepandemic baseline by the late pandemic (107 panels monthly/facility; sd 211). Relative to prepandemic, late pandemic testing involved more small panel use (58 monthly/facility, sd 156) and less large panel use (47 monthly/facility, sd 116). Comparisons among periods demonstrated significant differences in overall testing ( P < 0.0001), large panel use ( P < 0.0001), and small panel use ( P < 0.0001).
Conclusions
Postpandemic, clinical use of respiratory panel testing shifted from predominantly large panels to predominantly small panels. Factors driving this change may include resource availability, costs, and the clinical utility of targeting important pathogenic viruses instead of testing “for everything.”
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
- University of Maryland - Institute for Health Computing, North Bethesda, MD, USA.
- Pharmacy Research Computing, University of Maryland School of Pharmacy, Baltimore, MD, USA.
- Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.
- Maryland VA Health Care System, Baltimore, MD, USA.
ORCID-Profile: Jonathan D Baghdadi, Anthony D Harris
Förderung
- AHRQ HHS
Zitieren
APA
Baghdadi, J. D., Tung, C. C., Johnson, J. K., Morgan, D. J., & Harris, A. D. (2024). Changes in use of multiplex respiratory panel testing during the COVID-19 pandemic. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2024.163
Vancouver
Baghdadi JD, Tung CC, Johnson JK, Morgan DJ, Harris AD. Changes in use of multiplex respiratory panel testing during the COVID-19 pandemic. Infection Control & Hospital Epidemiology. 2024. doi:10.1017/ice.2024.163
BibTeX
@article{Baghdadi2024,
author = {Baghdadi, Jonathan D and Tung, Chih Chun and Johnson, J Kristie and Morgan, Daniel J and Harris, Anthony D},
title = {Changes in use of multiplex respiratory panel testing during the COVID-19 pandemic},
journal = {Infection Control & Hospital Epidemiology},
year = {2024},
doi = {10.1017/ice.2024.163}
}
EUVIMED